Sutent
Term · Oncology and biomedicine · MLC-T-ONC-008427
A drug used to treat adults with certain types of gastrointestinal stromal tumors, pancreatic neuroendocrine tumors, or renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Sutent blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Sutent is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called SU011248, SU11248, and sunitinib malate.
| Identifier | MLC-T-ONC-008427 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | SU011248; SU11248; sunitinib malate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-008427",
"term": "Sutent",
"field": "Oncology and biomedicine",
"definition": "A drug used to treat adults with certain types of gastrointestinal stromal tumors, pancreatic neuroendocrine tumors, or renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Sutent blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Sutent is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called SU011248, SU11248, and sunitinib malate.",
"synonyms": [
"SU011248",
"SU11248",
"sunitinib malate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/sutent/"
}
Record 15,849 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.